Related Experiment Video
Updated: Jul 15, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines
Arianna Bottoni1, Cristina Vignali, Daniela Piccin
1Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, Italy.
Abstract:
The aminoacyl t-RNA synthetase interacting multifunctional protein (AIMP1) is the precursor of the multifunctional inflammatory cytokine endothelial monocyte-activating polypeptide II (EMAP II). We previously demonstrated that AIMP1 secretion by pituitary adenomas is inversely correlated with tumor diameter and with RARS expression, suggesting that a high amount of RARS associated with AIMP1 might prevent the secretion of the latter cytokine. In this study, we investigated the role of RARS in modulating the secretion of AIMP1 in HeLa and MCF7 cell lines and investigated the possible role of the multicatalytic protease in the cleavage of AIMP1 to generate EMAP II. Our data show that RARS over-expression impairs AIMP1 secretion by both HeLa and MCF7 cells. Moreover, proteasome inhibition impairs AIMP1 cleavage to produce EMAP II. These data indicate that RARS over-expression associates with a reduced AIMP1 secretion and that the multicatalytic protease is involved in the generation of the mature cytokine, EMAP II.
Insights
High RARS expression reduces AIMP1 secretion and EMAP II generation. Proteasome inhibition also impairs EMAP II production, revealing key regulatory roles in cytokine processing.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Aminoacyl t-RNA synthetase interacting multifunctional protein (AIMP1) is a precursor to the inflammatory cytokine endothelial monocyte-activating polypeptide II (EMAP II).
- Previous studies suggested RARS (Ars) expression negatively correlates with AIMP1 secretion in pituitary adenomas.
Purpose of the Study:
- To investigate the role of RARS in modulating AIMP1 secretion in HeLa and MCF7 cell lines.
- To explore the involvement of the multicatalytic protease in cleaving AIMP1 to generate EMAP II.
Main Methods:
- Over-expression of RARS in HeLa and MCF7 cells.
- Proteasome inhibition experiments.
- Analysis of AIMP1 secretion and EMAP II generation.
Main Results:
- RARS over-expression significantly impaired AIMP1 secretion in both cell lines.
- Proteasome inhibition hindered the cleavage of AIMP1 into EMAP II.
- These findings link RARS levels to reduced AIMP1 secretion and protease activity to EMAP II formation.
Conclusions:
- RARS over-expression is associated with decreased AIMP1 secretion.
- The multicatalytic protease plays a crucial role in the generation of the mature cytokine EMAP II.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a superfamily...
Regulation of the Unfolded Protein Response
Abnormal Proliferation

